Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus.

Frank AC, Zhang X, Katsounas A, Bharucha JP, Kottilil S, Imamichi T.

J Interferon Cytokine Res. 2010 Jun;30(6):427-31. doi: 10.1089/jir.2009.0093.

2.

(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.

Wang YZ, Li JL, Wang X, Zhang T, Ho WZ.

World J Gastroenterol. 2017 Aug 28;23(32):5895-5903. doi: 10.3748/wjg.v23.i32.5895.

3.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

4.

CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R.

Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.

PMID:
22814930
5.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
6.

HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.

Mutz P, Metz P, Lempp FA, Bender S, Qu B, Schöneweis K, Seitz S, Tu T, Restuccia A, Frankish J, Dächert C, Schusser B, Koschny R, Polychronidis G, Schemmer P, Hoffmann K, Baumert TF, Binder M, Urban S, Bartenschlager R.

Gastroenterology. 2018 May;154(6):1791-1804.e22. doi: 10.1053/j.gastro.2018.01.044. Epub 2018 Feb 1.

7.

Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.

Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.

Hepatology. 2008 Jul;48(1):59-69. doi: 10.1002/hep.22289.

PMID:
18459156
8.

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Zhu H, Butera M, Nelson DR, Liu C.

Virol J. 2005 Sep 7;2:80.

9.

IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages.

Imamichi T, Yang J, Huang DW, Brann TW, Fullmer BA, Adelsberger JW, Lempicki RA, Baseler MW, Lane HC.

AIDS. 2008 Jan 2;22(1):39-45.

PMID:
18090390
10.

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Stegmann KA, Björkström NK, Ciesek S, Lunemann S, Jaroszewicz J, Wiegand J, Malinski P, Dustin LB, Rice CM, Manns MP, Pietschmann T, Cornberg M, Ljunggren HG, Wedemeyer H.

J Infect Dis. 2012 May 1;205(9):1351-62. doi: 10.1093/infdis/jis210. Epub 2012 Mar 29.

11.

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.

Abe H, Imamura M, Hiraga N, Tsuge M, Mitsui F, Kawaoka T, Takahashi S, Ochi H, Maekawa T, Hayes CN, Tateno C, Yoshizato K, Murakami S, Yamashita N, Matsuhira T, Asai K, Chayama K.

J Hepatol. 2011 Jul;55(1):11-8. doi: 10.1016/j.jhep.2010.10.017. Epub 2010 Nov 29.

PMID:
21145867
12.

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

Park H, Serti E, Eke O, Muchmore B, Prokunina-Olsson L, Capone S, Folgori A, Rehermann B.

Hepatology. 2012 Dec;56(6):2060-70. doi: 10.1002/hep.25897. Epub 2012 Nov 19.

13.

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W.

J Virol. 2013 Sep;87(17):9707-18. doi: 10.1128/JVI.00802-13. Epub 2013 Jul 3.

14.

Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.

Zhao LJ, Wang W, Liu Y, Ren H, Qi ZT.

Antiviral Res. 2012 Nov;96(2):260-8. doi: 10.1016/j.antiviral.2012.09.002. Epub 2012 Sep 15.

PMID:
22985631
15.

Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.

Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J.

J Hepatol. 2015 Oct;63(4):813-21. doi: 10.1016/j.jhep.2015.06.002. Epub 2015 Jun 10.

PMID:
26070407
16.

CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.

Ye L, Wang X, Wang S, Wang Y, Song L, Hou W, Zhou L, Li H, Ho W.

Hepatology. 2009 Mar;49(3):753-62. doi: 10.1002/hep.22715.

17.

Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.

Liu WL, Yang HC, Su WC, Wang CC, Chen HL, Wang HY, Huang WH, Chen DS, Lai MY.

PLoS One. 2012;7(9):e43824. doi: 10.1371/journal.pone.0043824. Epub 2012 Sep 4.

18.

Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Ye L, Wang X, Li J, Liu J, Ramirez SH, Wu J, Ho W.

Innate Immun. 2012 Jun;18(3):398-405. doi: 10.1177/1753425911412984. Epub 2011 Sep 22.

19.

[Effect of interferon inductors on infection induced by hepatitis C virus and activity of mRNA cytokines in cell cultures SW-13 and MT-4].

Narovlianskiĭ AN, Deriabin PG, Vershinina MIu, Mezentseva MV, Ershov FI.

Vopr Virusol. 2002 Nov-Dec;47(6):17-21. Russian.

PMID:
12508677
20.

Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.

Liu JP, Ye L, Wang X, Li JL, Ho WZ.

Transpl Infect Dis. 2011 Feb;13(1):24-32. doi: 10.1111/j.1399-3062.2010.00556.x. Epub 2010 Oct 7.

Supplemental Content

Support Center